<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this study was to investigate the clinical significances of the <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of survivin gene and its four splice variants in the pathogenesis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples, matched adjacent tissues, and <z:mpath ids='MPATH_458'>normal</z:mpath> tissues were collected from surgical resections of 39 patients with histologically confirmed diagnosis </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of survivin and its four splice variants, that is, survivin-△Ex3, survivin-2B, survivin-3B, and survivin-2α, was detected using semiquantitative PCR and RT-PCR </plain></SENT>
<SENT sid="3" pm="."><plain>Carcinoembryonic antigen (CEA) CAM5 was determined as control </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression rates of survivin, survivin-△Ex3, survivin-2B, survivin-3B, surviving-2α, and CEA CAM5 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples were significantly higher than those in adjacent tissues (P &lt; 0.01) and those in <z:mpath ids='MPATH_458'>normal</z:mpath> tissues (P &lt; 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of the above variants in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples were also significantly higher than those in adjacent tissues (P &lt; 0.01) and those in <z:mpath ids='MPATH_458'>normal</z:mpath> tissues (P &lt; 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of survivin, survivin-2B, and survivin-2α were not associated with any clinical variable of patients, while the levels of survivin-△Ex3 and survivin-3B were associated with lymphoid <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and Dukes grade (P &lt; 0.05), and survivin-△Ex3 was associated with invasiveness </plain></SENT>
<SENT sid="7" pm="."><plain>We concluded that <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression rates and levels of survivin and its four splice variants elevated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues, and expression levels of survivin-△Ex3 and survivin-3B were positively associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:hpo ids='HP_0000718'>aggression</z:hpo> </plain></SENT>
</text></document>